Zhao et al. confirmed that IL-6 could increase the expression levels of JAK, STAT3, phosphorylated-STAT3 and VEGF-C in GC cells, and can promote the growth, invasion, and lymphangiogenesis of GC through the JAK/STAT3/VEGF-C signaling pathway (110). The gene discussed is IL6; the disease is gastric cancer.